Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Oral Transmucosal Drugs Market Report 2024

Oral Transmucosal Drugs Global Market Report 2024 – By Product Type (Tablets, Films, Liquid And Spray, Other Product Types), By Indication (Opioid Dependence, Nausea And Vomiting, Erectile Dysfunction, Neurological Disorders, Other Indications), By Route Of Administration (Sublingual Mucosa, Buccal Mucosa, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

Oral Transmucosal Drugs Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : June 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Oral Transmucosal Drugs Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Oral Transmucosal Drugs Market Definition And Segments

Oral transmucosal drugs refer to medications formulated to be absorbed through the mucous membranes in the mouth, providing swift effects and bypassing initial metabolism in the liver and gastrointestinal tract. These drugs are commonly used for conditions requiring rapid relief, such as pain management, and for patients who have difficulty swallowing pills.

The main product types of oral transmucosal drugs are tablets, films, liquid and spray, and others. Tablets in the oral transmucosal drug refer to solid dosage forms intended for administration through the mucous membranes in the mouth. The indications are opioid dependence, nausea and vomiting, erectile dysfunction, neurological disorders, and others that are consumed via sublingual mucosa, buccal mucosa, and other routes of administration and distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The oral transmucosal drugs market covered in this report is segmented –

1) By Product Type: Tablets, Films, Liquid And Spray, Other Product Types

2) By Indication: Opioid Dependence, Nausea And Vomiting, Erectile Dysfunction, Neurological Disorders, Other Indications

3) By Route Of Administration: Sublingual Mucosa, Buccal Mucosa, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The oral transmucosal drugs market size has grown strongly in recent years. It will grow from $36.34 billion in 2023 to $39.70 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to advancements in diagnostic capabilities, aging demographics, environmental pollutants, genetic susceptibilities, enhanced detection rates, faster relief facilitated by fast drug absorption, and better adherence.

The oral transmucosal drugs market size is expected to see strong growth in the next few years. It will grow to $56.83 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to advancements in personalized medicine, increasing research on novel drug delivery systems, expanding geriatric population, growing awareness of oral health, rising demand for non-invasive treatments, and evolving regulatory landscapes. Major trends in the forecast period include adoption of novel formulations, personalized medicine approaches, telehealth advancements, integration of digital health technologies and technological innovations in pharmaceuticals.

Parkinson's Disease Driving Growth In Oral Transmucosal Drug Market

The rising incidence of Parkinson's disease is expected to propel the growth of the oral transmucosal drug market going forward. Parkinson's disease refers to a progressive neurological condition causing tremors, stiffness, and movement difficulties due to a reduction in dopamine-producing cells in the brain. The rising prevalence of Parkinson's disease is due to aging demographics, environmental pollutants, genetic susceptibilities, and advancements in diagnostic capabilities that enhance detection rates. Oral transmucosal drugs support Parkinson's disease treatment by facilitating fast drug absorption and overcoming digestive challenges, leading to faster relief, better adherence, and possibly fewer motor complications. For instance, in December 2022, according to the Parkinson's Foundation, a US-based non-profit organization, approximately 1 million individuals in the United States currently have Parkinson's disease (PD), which is expected to increase to 1.2 million by 2030. Therefore, the rising incidence of Parkinson's disease is driving the growth of the oral transmucosal drug market.

Major companies operating in the oral transmucosal drugs market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi-Aventis LLC, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Eli Lilly & Company Ltd., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Actavis Pharma Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Mallinckrodt Pharmaceuticals Plc, Glenmark Pharmaceuticals Limited, Jubilant Life Sciences Limited, Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Wockhardt Ltd.

Innovative Sublingual Vitamin Spray Revolutionizes Nutrient Delivery

Major companies operating in the oral transmucosal drug market focus on developing innovative drug delivery solutions, such as sublingual vitamin spray, to enhance drug delivery efficacy, improve patient convenience, and optimize therapeutic outcomes. A sublingual vitamin spray is an oral transmucosal drug delivery system that provides vitamins directly into the bloodstream via the mucous membranes under the tongue. This method bypasses the gastrointestinal tract and liver metabolism, allowing for rapid and efficient absorption of the vitamins. For instance, in October 2022, Vestige Marketing, an India-based wellness and fitness company, introduced Absorvit, a sublingual vitamin spray that provides swift absorption and rapid results. This innovative product offers 3–10 times greater absorption than traditional oral methods. It contains upgraded forms and precise doses of essential vitamins, including B12, C, D, and multivitamins, ensuring optimal nutrition delivery. Absorvit represents a convenient and efficient way to supplement vital nutrients, enhancing overall wellness.

XOMA's Acquisition Of DSUVIA From Talphera To Maximize Revenue

In January 2024, XOMA Corporation, a US-based biotechnology company, acquired DSUVIA from Talphera, Inc. for $8 million. Through this acquisition, XOMA seeks to maximize revenue from DSUVIA, a sufentanil sublingual tablet, while sharing profits and risks with Talphera and leveraging potential milestones from Alora Pharmaceuticals. Talphera Inc. is a US-based pharmaceutical company involved in developing oral transmucosal drugs.

North America was the largest region in the oral transmucosal drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral transmucosal drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral transmucosal drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral transmucosal drugs market consists of sales of buccal patches, sublingual tablets, lozenges, and oral transmucosal powders. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The oral transmucosal drugs market research report is one of a series of new reports from The Business Research Company that provides oral transmucosal drugs market statistics, including oral transmucosal drugs industry global market size, regional shares, competitors with oral transmucosal drugs market share, detailed oral transmucosal drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the oral transmucosal drugs industry. This oral transmucosal drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Oral Transmucosal Drugs Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $39.7 billion
Revenue Forecast In 2033 $56.83 billion
Growth Rate CAGR of 9.4% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product Type: Tablets, Films, Liquid And Spray, Other Product Types
2) By Indication: Opioid Dependence, Nausea And Vomiting, Erectile Dysfunction, Neurological Disorders, Other Indications
3) By Route Of Administration: Sublingual Mucosa, Buccal Mucosa, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi-Aventis LLC, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Eli Lilly & Company Ltd., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Actavis Pharma Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Mallinckrodt Pharmaceuticals Plc, Glenmark Pharmaceuticals Limited, Jubilant Life Sciences Limited, Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd, Wockhardt Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Oral Transmucosal Drugs Market Characteristics

    3. Oral Transmucosal Drugs Market Trends And Strategies

    4. Oral Transmucosal Drugs Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Oral Transmucosal Drugs Market Size and Growth

    5.1. Global Oral Transmucosal Drugs Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Oral Transmucosal Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Oral Transmucosal Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Oral Transmucosal Drugs Market Segmentation

    6.1. Global Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Tablets

    Films

    Liquid And Spray

    Other Product Types

    6.2. Global Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Opioid Dependence

    Nausea And Vomiting

    Erectile Dysfunction

    Neurological Disorders

    Other Indications

    6.3. Global Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Sublingual Mucosa

    Buccal Mucosa

    Other Routes Of Administration

    6.4. Global Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    7. Oral Transmucosal Drugs Market Regional And Country Analysis

    7.1. Global Oral Transmucosal Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Oral Transmucosal Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Oral Transmucosal Drugs Market

    8.1. Asia-Pacific Oral Transmucosal Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Oral Transmucosal Drugs Market

    9.1. China Oral Transmucosal Drugs Market Overview

    9.2. China Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Oral Transmucosal Drugs Market

    10.1. India Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Oral Transmucosal Drugs Market

    11.1. Japan Oral Transmucosal Drugs Market Overview

    11.2. Japan Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Oral Transmucosal Drugs Market

    12.1. Australia Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Oral Transmucosal Drugs Market

    13.1. Indonesia Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Oral Transmucosal Drugs Market

    14.1. South Korea Oral Transmucosal Drugs Market Overview

    14.2. South Korea Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Oral Transmucosal Drugs Market

    15.1. Western Europe Oral Transmucosal Drugs Market Overview

    15.2. Western Europe Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Oral Transmucosal Drugs Market

    16.1. UK Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Oral Transmucosal Drugs Market

    17.1. Germany Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Oral Transmucosal Drugs Market

    18.1. France Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Oral Transmucosal Drugs Market

    19.1. Italy Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Oral Transmucosal Drugs Market

    20.1. Spain Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Oral Transmucosal Drugs Market

    21.1. Eastern Europe Oral Transmucosal Drugs Market Overview

    21.2. Eastern Europe Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Oral Transmucosal Drugs Market

    22.1. Russia Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Oral Transmucosal Drugs Market

    23.1. North America Oral Transmucosal Drugs Market Overview

    23.2. North America Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Oral Transmucosal Drugs Market

    24.1. USA Oral Transmucosal Drugs Market Overview

    24.2. USA Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Oral Transmucosal Drugs Market

    25.1. Canada Oral Transmucosal Drugs Market Overview

    25.2. Canada Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Oral Transmucosal Drugs Market

    26.1. South America Oral Transmucosal Drugs Market Overview

    26.2. South America Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Oral Transmucosal Drugs Market

    27.1. Brazil Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Oral Transmucosal Drugs Market

    28.1. Middle East Oral Transmucosal Drugs Market Overview

    28.2. Middle East Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Oral Transmucosal Drugs Market

    29.1. Africa Oral Transmucosal Drugs Market Overview

    29.2. Africa Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Oral Transmucosal Drugs Market Competitive Landscape And Company Profiles

    30.1. Oral Transmucosal Drugs Market Competitive Landscape

    30.2. Oral Transmucosal Drugs Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Merck & Co. Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. AbbVie Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Sanofi-Aventis LLC

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AstraZeneca PLC

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Oral Transmucosal Drugs Market Other Major And Innovative Companies

    31.1. Abbott Laboratories

    31.2. Novartis AG

    31.3. GlaxoSmithKline plc

    31.4. Eli Lilly & Company Ltd.

    31.5. Boehringer Ingelheim International GmbH

    31.6. Viatris Inc.

    31.7. Teva Pharmaceutical Industries Ltd.

    31.8. Biogen Inc.

    31.9. Actavis Pharma Inc.

    31.10. Sun Pharmaceutical Industries Limited

    31.11. Dr. Reddy's Laboratories Ltd.

    31.12. Endo Pharmaceuticals Inc.

    31.13. Lupin Limited

    31.14. Zydus Lifesciences Limited

    31.15. Mallinckrodt Pharmaceuticals Plc

    32. Global Oral Transmucosal Drugs Market Competitive Benchmarking

    33. Global Oral Transmucosal Drugs Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Oral Transmucosal Drugs Market

    35. Oral Transmucosal Drugs Market Future Outlook and Potential Analysis

    35.1 Oral Transmucosal Drugs Market In 2028 - Countries Offering Most New Opportunities

    35.2 Oral Transmucosal Drugs Market In 2028 - Segments Offering Most New Opportunities

    35.3 Oral Transmucosal Drugs Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Oral Transmucosal Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Oral Transmucosal Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Merck & Co. Inc. Financial Performance
  • Table 77: AbbVie Inc. Financial Performance
  • Table 78: Sanofi-Aventis LLC Financial Performance
  • Table 79: AstraZeneca PLC Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Oral Transmucosal Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Oral Transmucosal Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Oral Transmucosal Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Oral Transmucosal Drugs Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Oral Transmucosal Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Oral Transmucosal Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Merck & Co. Inc. Financial Performance
  • Figure 77: AbbVie Inc. Financial Performance
  • Figure 78: Sanofi-Aventis LLC Financial Performance
  • Figure 79: AstraZeneca PLC Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Behavioral Biometrics Global Market Report 2024 – By Components (Software, Services), By Type (Keystroke Dynamics, Gait Analysis, Signature Analysis, Voice Recognition), By Deployment Model (Cloud, On-Premises), By Application (Identity Proofing, Continuous Authentication, Risk and Compliance Management, Fraud Detection and Prevention), By Verticals (Banking, Financial Services and Insurance (BFSI), Retail, e-Commerce, Healthcare, Government and Defense, Telecommunications, Other verticals) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Intratumoral Cancer Therapies Global Market Report 2024 – By Technology (Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Cell Therapies, Immunes System Modulator, Adoptive Cell Transfer, Cytokines ), By Application (Lung Cancer, Breast Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Other Applications ), By End Users (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pet Oral Care Products Global Market Report 2024 – By Product Type (Toothpaste, Toothbrushes, Dental Wipes, Dental Chews, Oral-Care Food Additives, Oral-Care Water Additives, Other Products), By Pet Type (Dogs, Cats, Other Pets), By Distribution Channel (Supermarkets And Hypermarkets, Online Channels, Specialized Pet Shops, Veterinary Channels, Other Distribution Channels), By Application (Residential, Commercial), By End-Use (Veterinary Hospitals, Private Clinics, Home Care, Colleges And Universities) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Behavioral Rehabilitation Global Market Report 2024 – By Treatment Method (Counseling, Medication, Support Services, Other Treatment Methods), By Application (Anxiety Disorders, Mood Disorders, Substance Abuse Disorders, Personality Disorders, Attention Deficit Disorders), By Healthcare Settings (Outpatient Behavioral Rehabilitation, Inpatient Behavioral Rehabilitation, Residential Behavioral Rehabilitation) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Oral Cancer Treatment Global Market Report 2024 – By Type (Oral Squamous Cell Carcinoma, Oral Verrucous Carcinoma, Mucoepidermoid Carcinoma, Oral Cavity Lymphomas), By Therapy Type (Chemotherapy, Radiation Therapy, Biological Therapy), By Route of Administration (Oral, Injectable, Other Routes Of Administration), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Computer-Aided Oral And Maxillofacial Surgery Global Market Report 2024 – By Component (Dental Printers, Milling Machine, Scanners, Software, Other Components), By Application (Dental Implantology, Orthognathic Surgery, Other Applications), By End User (Neurosurgery, Orthognathic and Dental Surgery, Plastic Surgery, Dental Surgery, Oral Surgery) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Oral Biologics & Biosimilar Drugs Global Market Report 2024 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn's Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Oral Contraceptive Pills Global Market Report 2024 – By Type (Combination, Progestin Only, Other Types), By Category (Generic, Branded), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the oral transmucosal drugs market?

Oral transmucosal drugs refer to medications formulated to be absorbed through the mucous membranes in the mouth, providing swift effects and bypassing initial metabolism in the liver and gastrointestinal tract. These drugs are commonly used for conditions requiring rapid relief, such as pain management, and for patients who have difficulty swallowing pills. For further insights on the oral transmucosal drugs market, request a sample here

How will the oral transmucosal drugs market drivers and restraints affect the oral transmucosal drugs market dynamics? What forces will shape the oral transmucosal drugs industry going forward?

The oral transmucosal drugs market major growth driver - Parkinson's Disease Driving Growth In Oral Transmucosal Drug Market. For further insights on the oral transmucosal drugs market, request a sample here

What is the forecast market size or the forecast market value of the oral transmucosal drugs market?

The oral transmucosal drugs market size has grown strongly in recent years. It will grow from $36.34 billion in 2023 to $39.70 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to advancements in diagnostic capabilities, aging demographics, environmental pollutants, genetic susceptibilities, enhanced detection rates, faster relief facilitated by fast drug absorption, and better adherence. The oral transmucosal drugs market size is expected to see strong growth in the next few years. It will grow to $56.83 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to advancements in personalized medicine, increasing research on novel drug delivery systems, expanding geriatric population, growing awareness of oral health, rising demand for non-invasive treatments, and evolving regulatory landscapes. Major trends in the forecast period include adoption of novel formulations, personalized medicine approaches, telehealth advancements, integration of digital health technologies and technological innovations in pharmaceuticals. For further insights on the oral transmucosal drugs market, request a sample here

How is the oral transmucosal drugs market segmented?

The oral transmucosal drugs market is segmented
1) By Product Type: Tablets, Films, Liquid And Spray, Other Product Types
2) By Indication: Opioid Dependence, Nausea And Vomiting, Erectile Dysfunction, Neurological Disorders, Other Indications
3) By Route Of Administration: Sublingual Mucosa, Buccal Mucosa, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online PharmaciesFor further insights on the oral transmucosal drugs market, request a sample here

Which region has the largest share of the oral transmucosal drugs market? What are the other regions covered in the report?

North America was the largest region in the oral transmucosal drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral transmucosal drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the oral transmucosal drugs market, request a sample here.

Who are the major players in the oral transmucosal drugs market?

Major companies operating in the oral transmucosal drugs market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sanofi-Aventis LLC, AstraZeneca PLC, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Eli Lilly & Company Ltd., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Actavis Pharma Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Endo Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Mallinckrodt Pharmaceuticals Plc, Glenmark Pharmaceuticals Limited, Jubilant Life Sciences Limited, Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd, Wockhardt Ltd. For further insights on the oral transmucosal drugs market, request a sample here.

What are the key trends in the oral transmucosal drugs market?

Major trend in the oral transmucosal drugs market - Innovative Sublingual Vitamin Spray Revolutionizes Nutrient Delivery. For further insights on the oral transmucosal drugs market, request a sample here.

What are the major opportunities in the oral transmucosal drugs market? What are the strategies for the oral transmucosal drugs market?

For detailed insights on the major opportunities and strategies in the oral transmucosal drugs market, request a sample here.

How does the oral transmucosal drugs market relate to the overall economy and other similar markets?

For detailed insights on oral transmucosal drugs market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the oral transmucosal drugs industry?

For detailed insights on the mergers and acquisitions in the oral transmucosal drugs industry, request a sample here.

What are the key dynamics influencing the oral transmucosal drugs market growth? SWOT analysis of the oral transmucosal drugs market.

For detailed insights on the key dynamics influencing the oral transmucosal drugs market growth and SWOT analysis of the oral transmucosal drugs industry, request a sample here.